Source: International Congress 2019 – Clinical challenges in respiratory infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Falynskova (Moscow, Russian Federation), I. Leneva (Moscow, Russian Federation), A. Egorov (Moscow, Russian Federation), A. Poddubikov (Moscow, Russian Federation), R. Grabherr (Vienna, Austria), M. Klausberger (Vienna, Austria). Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.. 4557

Member's Comments

No comment yet.

Related content which might interest you: Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Long-term outcomes after viral pneumonia caused by influenza A (H1N1) Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011 Comparison between community acquired pneumonia and influenza H1N1 pneumonia Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1 Source: Eur Respir J 2011; 38: 739-742 Year: 2011 Efficacy of the neuraminidase inhibitors in treating influenza pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 186s Year: 2004 Influenza vaccination is associated with reduced severity of community-acquired pneumonia Source: Eur Respir J 2011; 37: 147-153 Year: 2011 Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic Source: Eur Respir J 2011; 37: 106-111 Year: 2011 Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly Source: Eur Respir J 2010; 36: 608-614 Year: 2010 Pneumococcal and influenza vaccination Source: Respipedia Article Year: 2018 Immunomodulating effect of clarithromycin in a murine model of mycoplasma pneumoniae pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 737s Year: 2007 Bacterial coinfections in swine influenza (H1N1) pneumonia Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Immunological responses to influenza infection Source: Annual Congress 2006 - Influenza: from avian flu to pandemia? Year: 2006 Role of influenza virus infection in lung fibrosis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 The effect of influenza virus infection on airway inflammation in a murine model of asthma Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013